Unlock Accurate Precise Lab-Quality Pathogen Results in 15 Minutes On-Site.

Lab Quality Molecular Results—Where You Are, In Minutes

From sample to answer in minutes—no central lab, no shipping, just action.

Join the 10 µL Revolution: Lab-Grade Results, Anywhere

With as little as 10 µL, our platform provides precise biosensing and molecular readouts from a device that fits in your palm. Direct sensor measurement—no optics—cuts complexity while maintaining lab-grade specificity and selectivity.

Learn More

LOW COST

Low-cost disposables, by design.

A solid-state sensor and optics-free approach enable an affordable, single-use cartridge—lowering per-test cost without sacrificing performance.

FLEXIBLE

One platform, many sample types.

Configurable cartridges support liquids, swabs, surface wipes, and filter-based large-volume or gaseous sampling—so testing adapts to your environment, not the other way around.

QUANTIFY

Detect it—and measure it.

Beyond presence/absence, SensTek quantifies target concentration to track trends, verify treatment effectiveness, and support data-driven decisions.

MULTIPLEXED

Multiple answers, one device.

Run multi-target panels—or test groups for a single pathogen—on a single device to minimize size, weight, power, and total cost of ownership.

SPECIFICITY & SELECTIVITY

Isothermal amplification with rigor.

Proven isothermal amplification of RNA/DNA delivers the specificity and selectivity expected from lab-based methods, in a portable, on-site format.

Meet the SensTekDX Platform

Delivering lab-quality molecular results in minutes, SensTek empowers fast, informed decisions—right where they matter most. Our palm-sized platform brings sensitive, on-site detection with as little as 10 μL, engineered for speed, simplicity, and traceability.

HOW IT WORKS

STEP 01

Collect

Add your sample using the dropper. Use as little as 10 µL — no lab prep required.

❯❯

STEP 02

Load

Insert the cartridge into the MSX device with preloaded assay + secure QR code.

❯❯

STEP 03

Detect

Our solid-state electrochemical sensor amplifies & detects nucleic acids.

❯❯

STEP 04

View

Results appear securely in the SensTekDX app.

Uniting Expertise to Redefine Plant Pathology and Genetics Testing with CSP Labs

SensTek's groundbreaking testing platform with CSP Labs delivers rapid, on-site molecular diagnostics for agriculture applications. Our collaboration combines advanced portable testing with expert lab services— enabling fast, accurate pathogen detection and actionable results for seed growers and producers.

Learn More About CSP Labs
CSP Labs Logo

Trusted Voices On Our Mission

We are proud to be guided by leaders and advisors who are deeply committed to our mission. Here's why they believe in the future we're building together.

Manny Singh

" Early detection can save lives, yet access still stands in the way. After years of building systems that powered devices, I'm now focused on building a system that empowers people — a palm-sized diagnostic device that makes early disease detection simple, fast, and accessible to everyone. "

Manny Singh Co-founder & CEO

Dr. Deborah Ellis

" What struck me about SensTek wasn't just the technology, but its potential to completely change how we detect and respond to infectious threats. Confirmatory PCR at the point of care — truly PCR at your fingertips — closes the gap between testing and intervention. This is the future of active surveillance. "

Dr. Deborah Ellis, PhD, FACHE Healthcare Epidemiologist & Infectious Disease Leader

Dr. Terrence M. Cole

" I joined SensTek because I saw its technology as a bridge between innovation and health equity. Too often, early detection and diagnostic tools are limited to those with access to traditional healthcare systems. SensTek's platform changes this, bringing accurate, affordable, and rapid testing directly to communities, workplaces, and environments where timely information can save lives. I believe this technology has the power to transform public health by addressing the social determinants of health — access, affordability, and prevention — at their root. "

Dr. Terrence M. Cole, PhD

Ken Salsman

" We founded SensTek to develop a solid state sensor for the measurement of pH. We have used this to design a system to detect and measure the concentration of pathogens in the environment and in plants, animals and humans by measuring the amplification of DNA/RNA. We have a personal desire to see this provide improvements in the lives of people who have difficulty in getting the analysis and monitoring that they need for a healthy life. "

Ken Salsman Chief Technology Officer

Dwight Hicks

" Today it's imperative to see new technologies from a global perspective. SensTek's platforms sit on the cutting edge of health — from food safety to building safety — and reflect a responsible approach to the technologies of the future. That's why I wanted to be involved. "

Dwight Hicks, Super Bowl Champion Investor, Advisor

Jesse Lee

" SensTek proves diagnostics can be fast, affordable, and everywhere. The solid-state pH-LAMP approach strips out complexity and cost, bringing reliable testing to food safety, water quality, agriculture, animal health, and point-of-care diagnostics. It turns lab-grade insight into everyday protection. "

Jesse Lee Director of Marketing

Become Our Partner

Bring rapid, lab-quality molecular testing directly on-site across the world,
making early detection accessible wherever people live and work.

Partner with SensTek DIAGNOSTICS

LATEST NEWS

Latest News

PRESS RELEASE

JPM Healthcare Conference 2026

SensTek Diagnostics to Engage Strategic Partners at JPM Healthcare Conference 2026

Company opens one-on-one investor briefings during San Francisco's premier healthcare investor conference.

December 11, 2025

Go to Story

PRESS RELEASE

CES 2026

SensTek Diagnostics to Demo Real-Time, Solid-State Diagnostics Platform at CES 2026

Company opens exclusive demo bookings at Booth 4399 for CES attendees and OEM partners.

December 10, 2025

Go to Story

PRESS RELEASE

Medical Fair India 2026

Expanding Access to Rapid Molecular Testing at Medical Fair India 2026

SensTek will present portable molecular diagnostic platforms as part of the Official California Delegation at one of the world's largest healthcare trade exhibitions.

January 5, 2026

Go to Story

ANNOUNCEMENT

Silicon Catalyst Portfolio Company

Silicon Catalyst Announces Seven Newly Admitted Companies to Semiconductor Industry Accelerator

SensTekDx joins the newest Silicon Catalyst cohort, advancing solid-state molecular diagnostics alongside leading semiconductor innovators.

December 9, 2025

Go to Story